Intavitreal bevacizumab for choroidal neovascularization in a case of vitelliform macular dystrophy

Chieko Yasuda, Mineo Kondo, Shinji Ueno, Shigeo Yoshida, Tatsuro Ishibashi, Hiroko Terasaki

Research output: Contribution to journalArticle

Abstract

Purpose : To report a case of vitelliform macular dystrophy treated by intavitreal bevacizumab for choroidal neovascularization. Case : A 23-year-old female presented with suddenly impaired vision in her right eye. She had been diagnosed with vitelliform macular dystrophy when seen by an ophthalmologist for ocular trauma 8 years before. Findings : Corrected visual acuity was 0.5 right and 1.2 left. The right eye showed subretinal hemorrhage in the macular area. Fluorescein angiography showed findings suggestive of choroidal neovascularization in the macula. The right eye was treated by two sessions of intravireal bevacizumab at a 4-week interval. Visual acuity in the right eye improved to 1.0 3 months later. She has been doing well for 6 months until present. Conclusion : This case illustrates that intravitreal bevacizumab may be effective for choroidal neovascularization secondary to vitelliform macular dystrophy.

Original languageEnglish
Pages (from-to)1063-1067
Number of pages5
JournalJapanese Journal of Clinical Ophthalmology
Volume66
Issue number7
Publication statusPublished - Jul 1 2012

Fingerprint

Vitelliform Macular Dystrophy
Choroidal Neovascularization
Visual Acuity
Fluorescein Angiography
Bevacizumab
Hemorrhage
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

Intavitreal bevacizumab for choroidal neovascularization in a case of vitelliform macular dystrophy. / Yasuda, Chieko; Kondo, Mineo; Ueno, Shinji; Yoshida, Shigeo; Ishibashi, Tatsuro; Terasaki, Hiroko.

In: Japanese Journal of Clinical Ophthalmology, Vol. 66, No. 7, 01.07.2012, p. 1063-1067.

Research output: Contribution to journalArticle

Yasuda, Chieko ; Kondo, Mineo ; Ueno, Shinji ; Yoshida, Shigeo ; Ishibashi, Tatsuro ; Terasaki, Hiroko. / Intavitreal bevacizumab for choroidal neovascularization in a case of vitelliform macular dystrophy. In: Japanese Journal of Clinical Ophthalmology. 2012 ; Vol. 66, No. 7. pp. 1063-1067.
@article{fab1883b3e3d4c509b241231f833d3e9,
title = "Intavitreal bevacizumab for choroidal neovascularization in a case of vitelliform macular dystrophy",
abstract = "Purpose : To report a case of vitelliform macular dystrophy treated by intavitreal bevacizumab for choroidal neovascularization. Case : A 23-year-old female presented with suddenly impaired vision in her right eye. She had been diagnosed with vitelliform macular dystrophy when seen by an ophthalmologist for ocular trauma 8 years before. Findings : Corrected visual acuity was 0.5 right and 1.2 left. The right eye showed subretinal hemorrhage in the macular area. Fluorescein angiography showed findings suggestive of choroidal neovascularization in the macula. The right eye was treated by two sessions of intravireal bevacizumab at a 4-week interval. Visual acuity in the right eye improved to 1.0 3 months later. She has been doing well for 6 months until present. Conclusion : This case illustrates that intravitreal bevacizumab may be effective for choroidal neovascularization secondary to vitelliform macular dystrophy.",
author = "Chieko Yasuda and Mineo Kondo and Shinji Ueno and Shigeo Yoshida and Tatsuro Ishibashi and Hiroko Terasaki",
year = "2012",
month = "7",
day = "1",
language = "English",
volume = "66",
pages = "1063--1067",
journal = "Japanese Journal of Clinical Ophthalmology",
issn = "0370-5579",
publisher = "Igaku-Shoin Ltd",
number = "7",

}

TY - JOUR

T1 - Intavitreal bevacizumab for choroidal neovascularization in a case of vitelliform macular dystrophy

AU - Yasuda, Chieko

AU - Kondo, Mineo

AU - Ueno, Shinji

AU - Yoshida, Shigeo

AU - Ishibashi, Tatsuro

AU - Terasaki, Hiroko

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Purpose : To report a case of vitelliform macular dystrophy treated by intavitreal bevacizumab for choroidal neovascularization. Case : A 23-year-old female presented with suddenly impaired vision in her right eye. She had been diagnosed with vitelliform macular dystrophy when seen by an ophthalmologist for ocular trauma 8 years before. Findings : Corrected visual acuity was 0.5 right and 1.2 left. The right eye showed subretinal hemorrhage in the macular area. Fluorescein angiography showed findings suggestive of choroidal neovascularization in the macula. The right eye was treated by two sessions of intravireal bevacizumab at a 4-week interval. Visual acuity in the right eye improved to 1.0 3 months later. She has been doing well for 6 months until present. Conclusion : This case illustrates that intravitreal bevacizumab may be effective for choroidal neovascularization secondary to vitelliform macular dystrophy.

AB - Purpose : To report a case of vitelliform macular dystrophy treated by intavitreal bevacizumab for choroidal neovascularization. Case : A 23-year-old female presented with suddenly impaired vision in her right eye. She had been diagnosed with vitelliform macular dystrophy when seen by an ophthalmologist for ocular trauma 8 years before. Findings : Corrected visual acuity was 0.5 right and 1.2 left. The right eye showed subretinal hemorrhage in the macular area. Fluorescein angiography showed findings suggestive of choroidal neovascularization in the macula. The right eye was treated by two sessions of intravireal bevacizumab at a 4-week interval. Visual acuity in the right eye improved to 1.0 3 months later. She has been doing well for 6 months until present. Conclusion : This case illustrates that intravitreal bevacizumab may be effective for choroidal neovascularization secondary to vitelliform macular dystrophy.

UR - http://www.scopus.com/inward/record.url?scp=84864401995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864401995&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84864401995

VL - 66

SP - 1063

EP - 1067

JO - Japanese Journal of Clinical Ophthalmology

JF - Japanese Journal of Clinical Ophthalmology

SN - 0370-5579

IS - 7

ER -